Allotera Therapeutics, Inc. of ST. LOUIS, MO, a company, filed a Form D amendment with the SEC on 2026-07-23. The offering totals $163.0M, of which $123.3M was reported sold. Industry: Other Health Care.
Showing 25 of 35 people.
| Name | Role | Location |
|---|---|---|
| Matthew Cooper | Related Person | Ann Arbor, MI |
| Drew Dennison | Related Person | St. Louis, MO |
| Bosun Hau | Related Person | St. Louis, MO |
| Ayman Kabakibi | Related Person | St. Louis, MO |
| Peter Kiener | Related Person | St. Louis, MO |
| Kevin Li | Related Person | Carlsbad, CA |
| Natalie Mount | Related Person | St. Louis, MO |
| Bali Muralidhar | Related Person | St. Louis, MO |
| Niall O'Donnell | Related Person | St. Louis, MO |
| Kumar Srinivasan | Related Person | St. Louis, MO |
| Cherry Thomas | Related Person | St. Louis, MO |
| Matthew Cooper | Executive Officer | Ann Arbor, MI |
| Bali Muralidhar | Director | St. Louis, MO |
| Natalie Mount | Director | St. Louis, MO |
| Ayman Kabakibi | Executive Officer | St. Louis, MO |
| Drew Dennison | Director | St. Louis, MO |
| Niall O'Donnell | Director | St. Louis, MO |
| Bosun Hau | Director | St. Louis, MO |
| Kevin Li | Director | Carlsbad, CA |
| Peter Kiener | Director | St. Louis, MO |
| Cherry Thomas | Executive Officer | St. Louis, MO |
| Kumar Srinivasan | Director | St. Louis, MO |
| Kumar Srinivasan | Executive Officer | St. Louis, MO |
| Keith Vendola | Executive Officer | St. Louis, MO |
| Daniel M Kemp | Director | St. Louis, MO |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-09-08 | D | $163.0M | $109.5M |
| 2021-07-23 | D | $172.0M | $98.5M |
| 2021-07-23 | D | $37.2M | $37.2M |